X0508 4 2025-11-10 false 0001050446 Strategy Inc MSTR 0001663488 Shao Wei-Ming C/O STRATEGY INC 1850 TOWERS CRESCENT PLAZA TYSONS CORNER VA 22182 false true false false EVP & General Counsel true Class A Common Stock 2025-11-10 4 M false 5334 69.123 A 18060 D Class A Common Stock 2025-11-10 4 S false 3767 248.942 D 14293 D Class A Common Stock 2025-11-10 4 S false 1567 249.555 D 12726 D Class A Common Stock 2025-11-11 4 M false 5334 69.123 A 18060 D Class A Common Stock 2025-11-11 4 S false 3206 234.749 D 14854 D Class A Common Stock 2025-11-11 4 S false 1539 235.594 D 13315 D Class A Common Stock 2025-11-11 4 S false 589 236.455 D 12726 D Series A Perpetual Strife Preferred Stock 500 D Series A Perpetual Stretch Preferred Stock 15000 D Series A Perpetual Stride Preferred Stock 3527 D Employee Stock Option (Right to buy) 69.123 2025-11-10 4 M false 5334 0 D 2031-02-23 Class A Common Stock 5334 194666 D Employee Stock Option (Right to buy) 69.123 2025-11-11 4 M false 5334 0 D 2031-02-23 Class A Common Stock 5334 189332 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on July 11, 2025. As previously disclosed in Strategy Inc's ("Strategy") Current Report on Form 8-K filed with the Securities and Exchange Commission on July 1, 2025, the reporting person informed the issuer of his intention to retire effective December 31, 2025. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.435 to $249.40, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.52 to $250.04, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.25 to $235.17, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.39 to $236.235, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. The 5,334 shares exercised on November 10, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 194,666 shares subject to this option, 44,666 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. The 5,334 shares exercised on November 11, 2025 pursuant to this option vested on February 23, 2022. Of the remaining 189,332 shares subject to this option, 39,332 shares vested on February 23, 2022, 50,000 shares vested on February 23, 2023, 50,000 shares vested on February 23, 2024 and 50,000 shares vested on February 23, 2025. /s/ Allein Sabel, Attorney-in-Fact 2025-11-12